This is the latest study linking shorter telomeres to disease (there are over 10,000) that once again falls victim to proving obvious yet useless information. In this study, they linked smaller hippocampal volumes (seen in Alzheimer’s) with shorter white blood cell telomeres in a subset of women with a genetic prediliction for Alzheimers (the abnormal ApoE3 gene).
For today’s #ScienceSunday, I am going to have to discuss a murky subject brought on by the recent telomere results of my patients which arguably showed massive improvements in telomere length without commensurate increases in biological age. Here is the email I received:
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
